Vanillin flavoring in e-cigarettes disrupt human embryonic stem cell development, lab study finds
Vanillin, a common flavoring chemical in e-cigarettes, may disrupt the normal development of embryos in pregnant women who vape, according to a study published in Human Reproduction. The finding explains how vaping may be linked to women having difficulty conceiving and to miscarriages.
A recent laboratory study published in Human Reproduction has found that the flavoring chemical vanillin, commonly used in e-cigarettes, may disrupt the development of human embryonic stem cells. The research, conducted by a team from the University of California, Riverside, exposed embryonic stem cells to low and high concentrations of vanillin, as well as a chemical that blocks vanillin's interaction with a protein called TRPV4.
The results showed that higher concentrations of vanillin killed the stem cells, while lower concentrations caused them to lose their ability to differentiate into various cell types. This effect was linked to the activation of TRPV4, which allows calcium to enter the cells and trigger changes in their development. The study's lead author, Prue Talbot, emphasized the need for further investigation into the potential risks of vanillin exposure during pregnancy.
She suggested that women, especially those experiencing difficulty conceiving or miscarriages, should be cautious about vaping and consult with their healthcare providers. Additionally, the researchers called for stricter regulations and mandatory ingredient disclosure on e-cigarette packaging to inform consumers about the potential dangers to unborn children.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
